Question · Q3 2025
Michael Cherney from Leerink Partners asked for insights into the strong organic price per mix, particularly how much of this growth is driven by proactive company strategies versus market dynamics, and its sustainability beyond the current year.
Answer
Chairman and CEO Adam Schechter provided context on diagnostics revenue growth, while EVP and CFO Julia Wang explained that the 2.8% organic price mix increase was primarily due to a favorable mix, including a rise in tests per session and the annualization of Invitae. She projected continued mix growth supported by hospital partnerships, an aging population, health and wellness trends, and specialty testing.